Wells Fargo raised its price target on Church & Dwight Co., Inc. ($CHD) to $110 and maintained an overweight rating, citing the company’s strong brand portfolio and growth prospects. The upgrade comes after $CHD reported solid quarterly earnings, driven by increased demand for its consumer goods products, including Arm & Hammer and OxiClean.
Church & Dwight Co., Inc. ($CHD) is a leading manufacturer and marketer of consumer goods, with a diverse portfolio of brands across various categories. The company’s products are sold globally, with a significant presence in the United States, Canada, and other international markets. Church & Dwight Co., Inc. has a long history of delivering strong financial performance, with a focus on innovation, marketing, and strategic acquisitions.
The upgrade by Wells Fargo is a significant development, as it reflects the company’s confidence in $CHD’s ability to sustain its growth momentum. The new price target of $110 represents a significant increase from the previous target, and is likely to have a positive impact on the stock’s performance. $CHD’s shares have been trading strongly in recent months, driven by the company’s solid earnings growth and attractive valuation multiples.
The consumer goods sector has been experiencing a resurgence in recent months, driven by increased demand for household and personal care products. Wells Fargo is one of the leading research firms covering the sector, and its upgrade of $CHD is likely to be closely watched by investors. Other major players in the sector, including Procter & Gamble ($PG) and Unilever ($UL), are also likely to be impacted by the trends driving $CHD’s growth.
| Company | Price Target | Rating |
|---|---|---|
| Church & Dwight Co., Inc. ($CHD) | $110 | Overweight |
Looking ahead, the upgrade by Wells Fargo is likely to have significant implications for $CHD’s stock price and the broader consumer goods sector. As investors continue to seek out growth opportunities in a challenging market environment, $CHD’s strong brand portfolio and growth prospects make it an attractive option. The company’s ability to innovate and adapt to changing consumer trends will be key to sustaining its growth momentum, and investors will be closely watching its future earnings reports for signs of continued strength.
⚡ Why it matters: The upgrade of $CHD by Wells Fargo reflects the company’s strong growth prospects and attractive valuation multiples, making it a key stock to watch in the consumer goods sector.
📊 By the numbers:
New price target: $110
Previous price target: Not disclosed
$CHD’s market capitalization: Approximately $25 billion
🔗 Source: [Wells Fargo research report]*
🔄 TAKE 2 – 08:02 PM ET
UBS lowered its price target on $SFM to $75 from $108 previously and maintained a Neutral rating. The downgrade comes as $SFM, a leading healthy grocery store chain, faces increasing competition in the market and struggles to maintain its growth momentum.
Sprouts Farmers Market, Inc. ($SFM) has been a key player in the health food retail space, with a strong presence in the western United States. The company has focused on providing high-quality, healthy food options to its customers, which has helped it to build a loyal customer base. However, the health food retail space has become increasingly competitive, with other players such as Whole Foods Market and Trader Joe’s expanding their presence.
The downgrade by UBS is likely a reflection of the challenges $SFM is facing in maintaining its growth momentum. The company has been investing heavily in its e-commerce platform and expanding its store footprint, but the returns on these investments have been slower than expected. Additionally, $SFM has been facing pressure on its margins due to increasing competition and higher labor costs. As a result, the company’s stock price has been under pressure, and the downgrade by UBS is likely to add to the downward momentum.
In terms of key metrics, $SFM’s same-store sales growth has been slowing down, and the company’s gross margin has been under pressure. The following table summarizes some of the key metrics for $SFM:
| Metric | Q4 2025 | Q4 2024 |
|---|---|---|
| Same-store sales growth | 2.5% | 4.2% |
| Gross margin | 30.5% | 31.2% |
The slowdown in same-store sales growth and the decline in gross margin are likely to be key concerns for investors and analysts.
Looking ahead, $SFM will need to focus on driving growth and improving its margins in order to regain investor confidence. The company will need to continue to invest in its e-commerce platform and expand its store footprint, while also focusing on improving its operational efficiency and reducing costs. Additionally, $SFM will need to navigate the increasingly competitive health food retail space and differentiate itself from its competitors.
⚡ Why it matters: The downgrade by UBS is a significant development for $SFM, as it reflects the challenges the company is facing in maintaining its growth momentum. The downgrade is likely to add to the downward momentum in $SFM’s stock price, making it a key development for investors to watch.
📊 By the numbers:
New price target: $75
Previous price target: $108
Rating: Neutral
🔗 Source: UBS*
